1. Home
  2. XERS vs RMIX Comparison

XERS vs RMIX Comparison

Compare XERS & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$8.85

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Suncrete Inc. Class A Common Stock

RMIX

Suncrete Inc. Class A Common Stock

N/A

Current Price

$17.53

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
XERS
RMIX
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
XERS
RMIX
Price
$8.85
$17.53
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$10.83
N/A
AVG Volume (30 Days)
1.6M
212.0K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
N/A
N/A
Revenue
$49,590,000.00
N/A
Revenue This Year
$34.37
N/A
Revenue Next Year
$22.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
142.67
N/A
52 Week Low
$5.25
$16.59
52 Week High
$10.08
$25.50

Technical Indicators

Market Signals
Indicator
XERS
RMIX
Relative Strength Index (RSI) 59.95 40.34
Support Level $6.98 $17.05
Resistance Level $9.01 $20.01
Average True Range (ATR) 0.35 1.29
MACD 0.03 0.09
Stochastic Oscillator 94.66 29.58

Price Performance

Historical Comparison
XERS
RMIX

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

About RMIX Suncrete Inc. Class A Common Stock

Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.

Share on Social Networks: